SA-B prevented from liver fibrosis in CCl4- and DMN-treated models, which were probably related to downregulating the Ang II signaling pathway by AT1R, ERK, and c-Jun phosphorylation and by regulating the NF-κB/IkBα signaling pathway [151, 152]. The gene discussed is NFKB1; the disease is Hepatic fibrosis.